Elevance Health, Inc. (LON: 0HG8)
London
· Delayed Price · Currency is GBP · Price in USD
408.50
+16.93 (4.32%)
Jan 23, 2025, 1:26 PM BST
Elevance Health Revenue
Elevance Health had revenue of $45.15B USD in the quarter ending September 30, 2024, with 5.36% growth. This brings the company's revenue in the last twelve months to $174.02B, up 3.20% year-over-year. In the year 2023, Elevance Health had annual revenue of $171.34B with 9.41% growth.
Revenue (ttm)
$174.02B
Revenue Growth
+3.20%
P/S Ratio
n/a
Revenue / Employee
$1.66M
Employees
104,900
Market Cap
73.58B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | 104.21B | 12.12B | 13.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Elevance Health News
- 21 hours ago - Elevance Health Q4 2024 Earnings Preview - Seeking Alpha
- 1 day ago - Mark Farrah Associates Delves into Acquisition Impacts Utilizing New Tools - Business Wire
- 6 days ago - Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On? - Benzinga
- 6 days ago - Here's How Much $100 Invested In Elevance Health 20 Years Ago Would Be Worth Today - Benzinga
- 13 days ago - Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025 - Business Wire
- 20 days ago - My Top 15 High Growth Dividend Stocks For January 2025 - Seeking Alpha
- 20 days ago - Media Insider: Five for 2025 - Media leaders on the year ahead: NZME’s Michael Boggs, Stuff’s Sinead Boucher, Are Media’s Stuart Dick, D3′s Alex Radford, Lassoo Media’s Bridgette Smith, Anthem’s Jane Sweeney - NZ Herald
- 4 weeks ago - Elevance Health Is An Undervalued Healthcare Juggernaut - Seeking Alpha